查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590884

H1N1 疫苗市場：按給藥途徑、品牌類型和分銷管道分類 - 2025-2030 年全球預測

H1N1 Vaccines Market by Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, Intranasal Vaccines), Type of Brand (Agripal, Fiuarix, Influgen), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年H1N1疫苗市值為99.3億美元，預計2024年將達到134.5億美元，複合年成長率為35.51%，2030年將達到833.9億美元。

H1N1 疫苗市場的範圍和定義圍繞著對抗 H1N1 流感病毒（俗稱豬流感）的疫苗的開發、生產和分銷。這些疫苗的需求源自於流感大流行造成的全球健康風險，流感大流行導致廣泛的疾病和死亡。主要用途包括對高風險族群進行免疫接種，例如醫護人員、兒童、老年人和免疫力較弱的人。最終用途廣泛，包括公共衛生活動、醫院和臨床環境以及政府儲存策略。市場成長的推動因素包括感染疾病預防意識的增強、疫苗技術的進步以及政府衛生政策的支持。最近的市場趨勢凸顯了新興市場的擴張潛力，利用mRNA技術快速開拓疫苗，以及加強低溫運輸物流以確保疫苗的穩定性和到達偏遠地區都強調有機會。抓住這些機會的研究包括投資下一代疫苗的先進研究和開發（R&D）、建立廣泛的分銷網路的戰略夥伴關係以及加強衛生基礎設施的公私夥伴關係，其中包括參與合作。

主要市場統計
基準年[2023] 99.3億美元
預測年份 [2024] 134.5億美元
預測年份 [2030] 833.9億美元
複合年成長率（%） 35.51%

然而，限制因素包括推遲疫苗核准的監管障礙、全球分配中的政治和後勤挑戰，以及公眾對疫苗的猶豫不決以及錯誤訊息的加劇。應對這些挑戰需要持續的教育工作以及關於疫苗安全性和有效性的透明溝通。最具創新潛力的領域包括開發通用流感疫苗、加強疫苗儲存和輸送系統，以及整合數位衛生技術以更好地追蹤和管理疫苗分發。對這個市場性質的考察表明，在應對緊急公共衛生需求和預測未來疫情爆發的雙重迫切需求的推動下，該市場競爭激烈且發展迅速。成功進入這個市場需要戰略遠見和敏捷性，以應對疫苗市場特有的複雜性。

市場動態：揭示快速發展的 H1N1 疫苗市場的關鍵市場洞察

H1N1 疫苗市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 新增流感感染人數增加
    • 孕婦和兒童對去活化流感疫苗的需求
    • 轉向基於細胞的製造
  • 市場限制因素
    • 製造過程耗時且昂貴
  • 市場機會
    • 官民合作關係實現具有成本效益的供應
    • 疫苗技術進步
  • 市場挑戰
    • H1N1 疫苗的常見副作用

波特五力：駕馭 H1N1 疫苗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 H1N1 疫苗市場的外部影響

外部宏觀環境因素對甲型H1N1疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解甲型H1N1流感疫苗市場競爭狀況

對 H1N1 疫苗市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 H1N1 疫苗市場供應商績效評估

FPNV定位矩陣是評估H1N1疫苗市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪 H1N1 疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，H1N1 疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 流行性 H1N1 流感感染疾病發生率上升
      • 孕婦和兒童對去活化流感疫苗的需求
      • 過渡到基於細胞的製造
    • 抑制因素
      • 製造過程耗時且成本高
    • 機會
      • 官民合作關係實現具有成本效益的供應
      • 疫苗技術進步
    • 任務
      • H1N1 疫苗的常見副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 H1N1 疫苗市場：依給藥途徑

  • 皮內疫苗
  • 肌內疫苗
  • 鼻內疫苗

第7章 H1N1 疫苗品牌市場

  • 阿格里帕爾
  • 費里克斯
  • 流感
  • 流感回來
  • 納索瓦茨
  • 瓦克西握把

第8章 H1N1 疫苗市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 美洲H1N1疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區H1N1疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲H1N1疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Baxter International Inc.
  • Cipla Limited
  • Cochin Shipyard Ltd.
  • Glaxo Smith Kline
  • Hualan Biological Engineering Inc.
  • MedImmune, LLC
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Sanofi SA
  • Sinovac Biotech Ltd.
Product Code: MRR-437E9896A50B

The H1N1 Vaccines Market was valued at USD 9.93 billion in 2023, expected to reach USD 13.45 billion in 2024, and is projected to grow at a CAGR of 35.51%, to USD 83.39 billion by 2030.

The H1N1 vaccine market scope and definition revolve around the development, production, and distribution of vaccines aimed at combating the H1N1 influenza virus, commonly known as swine flu. The necessity for these vaccines stems from the global health risk presented by flu outbreaks, which can lead to widespread illness and mortality. Applications primarily include immunization efforts targeting high-risk populations such as healthcare workers, children, the elderly, and those with compromised immune systems. End-use scope spans public health initiatives, hospital and clinical settings, and government stockpiling strategies. Market growth is driven by factors such as increasing awareness of infectious disease prevention, advancements in vaccine technology, and supportive governmental health policies. Recent market dynamics highlight potential opportunities in the expansion within emerging markets, leveraging mRNA technology for rapid vaccine development, and enhancing cold chain logistics to ensure vaccine stability and reach in remote areas. Recommendations to seize these opportunities include investing in advanced research and development (R&D) for next-generation vaccines, forging strategic partnerships for broad distribution networks, and engaging in public-private collaborations to enhance health infrastructure.

KEY MARKET STATISTICS
Base Year [2023] USD 9.93 billion
Estimated Year [2024] USD 13.45 billion
Forecast Year [2030] USD 83.39 billion
CAGR (%) 35.51%

However, limitations include regulatory hurdles that can delay vaccine approval, political and logistical challenges in global distribution, and public vaccine hesitancy amplified by misinformation. Addressing these challenges calls for continuous education efforts and transparent communication about vaccine safety and efficacy. The best possible areas of innovation involve developing universal flu vaccines, enhancing vaccine storage and delivery systems, and integrating digital health technologies for better tracking and managing vaccine distribution. Insight into the nature of this market reveals it to be highly competitive and rapidly evolving, driven by the dual imperatives of addressing immediate public health needs and anticipating future outbreaks. Successful engagement requires strategic foresight and agility to navigate the complexities inherent in the vaccine landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving H1N1 Vaccines Market

The H1N1 Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of epidemic H1N1 infection
    • Demand for inactivated influenza vaccine in pregnant women and children
    • Shift towards cell-based manufacturing
  • Market Restraints
    • Time consuming manufacturing process and high cost
  • Market Opportunities
    • Public-private partnerships for cost effective supply
    • Technological advancements in the vaccines
  • Market Challenges
    • Common side effects associated with H1N1 vaccines

Porter's Five Forces: A Strategic Tool for Navigating the H1N1 Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the H1N1 Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the H1N1 Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the H1N1 Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the H1N1 Vaccines Market

A detailed market share analysis in the H1N1 Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the H1N1 Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the H1N1 Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the H1N1 Vaccines Market

A strategic analysis of the H1N1 Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the H1N1 Vaccines Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc., Cipla Limited, Cochin Shipyard Ltd., Glaxo Smith Kline, Hualan Biological Engineering Inc., MedImmune, LLC, Merck KGaA, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Sanofi S.A., and Sinovac Biotech Ltd..

Market Segmentation & Coverage

This research report categorizes the H1N1 Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines.
  • Based on Type of Brand, market is studied across Agripal, Fiuarix, Influgen, Influvac, Nasovac, and Vaxigrip.
  • Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of epidemic H1N1 infection
      • 5.1.1.2. Demand for inactivated influenza vaccine in pregnant women and children
      • 5.1.1.3. Shift towards cell-based manufacturing
    • 5.1.2. Restraints
      • 5.1.2.1. Time consuming manufacturing process and high cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Public-private partnerships for cost effective supply
      • 5.1.3.2. Technological advancements in the vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Common side effects associated with H1N1 vaccines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. H1N1 Vaccines Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intradermal Vaccines
  • 6.3. Intramuscular Vaccines
  • 6.4. Intranasal Vaccines

7. H1N1 Vaccines Market, by Type of Brand

  • 7.1. Introduction
  • 7.2. Agripal
  • 7.3. Fiuarix
  • 7.4. Influgen
  • 7.5. Influvac
  • 7.6. Nasovac
  • 7.7. Vaxigrip

8. H1N1 Vaccines Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas H1N1 Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific H1N1 Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa H1N1 Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Baxter International Inc.
  • 3. Cipla Limited
  • 4. Cochin Shipyard Ltd.
  • 5. Glaxo Smith Kline
  • 6. Hualan Biological Engineering Inc.
  • 7. MedImmune, LLC
  • 8. Merck KGaA
  • 9. Mitsubishi Tanabe Pharma Corporation
  • 10. Pfizer Inc.
  • 11. Sanofi S.A.
  • 12. Sinovac Biotech Ltd.

LIST OF FIGURES

  • FIGURE 1. H1N1 VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. H1N1 VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. H1N1 VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. H1N1 VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGRIPAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY FIUARIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY INFLUVAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY NASOVAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2023